Summary. Holstein heifers were given 5 injections (twice/day) of 10 ml charcoalextracted bovine follicular fluid (bFF; N = 6) or 10 ml saline (N = 5) beginning 12 h after the onset of oestrus. Blood samples were collected for determination of plasma concentrations of FSH, LH, progesterone and oestradiol-17\s=b\. Treatment with bFF suppressed the secondary FSH surge (P < 0\m=.\01). Cessation of bFF injections was followed by a rebound period during which FSH was elevated compared with controls (P < 0\m=.\01).Daily ultrasonographic examinations revealed that follicular growth occurred in waves, with 4 of 5 control heifers exhibiting 3 waves and the other 2 waves.
Introduction
The pituitary gonadotrophins LH and FSH are both necessary for ovarian follicular development (Greep et al., 1942) , but the relative roles of these hormones in stimulating folliculogenesis are not fully understood. During the bovine oestrous cycle, preovulatory surges of LH and FSH occur simultaneously (Dobson, 1978; and basal plasma concentrations are parallel throughout much of the luteal phase (Rahe et al., 1980; Schallenberger et ai, 1985) . However, circulating levels of LH and FSH are clearly divergent during two periods of the oestrous cycle in cattle, suggesting that these times may be critical for ovarian follicular stimulation by appropriate concentrations of each gonadotrophin. Following luteolysis, increases in basal LH and *Reprint requests to: Dr J. E. Fortune, 823 Veterinary Research Tower, Cornell University, Ithaca, New York 14853, USA. LH pulse frequency (Rahe et al., 1980) are accompanied by decreased FSH concentrations (Butler et ai, 1983; Schallenberger et al., 1984) . Patterns of LH and FSH also differ early in the luteal phase, when there is a second increase in plasma FSH but there is no concomitant rise in LH (Dobson, 1978; Roche & Ireland, 1981; . There is evidence that a similar secondary 'surge' in FSH is important for development of follicles for the next ovulatory cycle in rats (Grady et al., 1982) . The magnitude of the secondary FSH surge was higher in sheep of the prolific Romanov breed than in less prolific Ile-de-France ewes (Cahill et al, 1981) , suggesting that concentrations of FSH early in the oestrous cycle might be related to later growth of follicles. To our knowledge, the relationship of this periovulatory rise in FSH to subsequent follicular development in cattle has not been examined previously.
Ultrasonographic studies have shown that follicular growth in heifers occurs in 2 or 3 successive waves per oestrous cycle Savio et al., 1988; Knopf et al., 1989) . Each wave of growth is characterized by the recruitment of a group of follicles, with selection of one large dominant follicle. It is usually the dominant follicle of the third wave that ovulâtes. The precise endocrine control of these patterns of follicular recruitment, selection, growth and regression, particularly during the early and mid-luteal phase, remains a mystery.
Bovine follicular fluid (bFF) contains the glycoprotein inhibin (Robertson et ai, 1985) which selectively suppresses the synthesis and secretion of FSH from pituitary cells in vitro (see de Jong, 1988) . Injection of bFF suppressed circulating concentrations of FSH in vivo without altering plasma LH in ovariectomized and intact heifers. In the present study, bFF was used to suppress the secondary FSH surge in order to examine the role of this increase in FSH in determining patterns of follicular development in the heifer. A brief report has appeared in abstract form (Turzillo & Fortune, 1989 (Day 0 = oestrus) . Beginning 48 h after PGF-2u injection, heifers were observed for oestrous behaviour at 4-h intervals. Onset of oestrus was identified as the first observation period when a heifer would stand to be mounted by another heifer. Six heifers were treated with 10 ml charcoal-extracted bovine follicular fluid (bFF, preparation described below) i.v. at 12-h intervals from 12 to 60 h after onset of oestrus. Five control animals received 10 ml 0-9% saline (0T54M-NaO) injections in the same fashion. Collection of blood samples via jugular cannulae (Abbocath; 14 G 140 cm, Abbott Hospitals Inc., North Chicago, IL, USA) began 48 h after PGF-2a injection and was continued at 4-h intervals until 132 h after onset of oestrus. Heparin-saline (200 i.u./ml) was used to fill cannulae after each sample was taken. Daily samples were collected by venepuncture for the remainder of the oestrous cycle. Plasma was harvested from all samples and stored at -20°C for later measurement of FSH, LH, progesterone and oestradiol-17ß by radioimmunoassays (RIA).
Ultrasonographic examinations of ovaries were performed daily using a real-time B-mode linear array ultrasound scanner equipped with a 7-5 MHz intrarectal probe (Technicare 210DX; Corametrics, North Branford, CT, USA). The procedure used in our laboratory for monitoring ovarian follicular dynamics has been described previously in detail All bFF collections were thawed and pooled for charcoal-extraction of steroids (Bolt & Rollins, 1983; Butler et al., 1983; . Reagents were obtained from the USDA Animal Hormone Program. These included antiserum to the bovine FSH-ß subunit (USDA-5-0122), immunochemical grade FSH for preparation of labelled ligand (USDA-FSH-BP3), and biological grade FSH for standard (USDA-bFSH-B-1; biological potency 1-7 x NIH-FSH-B1). FSH was radioiodinated using Iodogen (Pierce Chemical Co., Rockford, IL, USA). The second antibody was goat anti-rabbit immunoglobulin G (ICN Immunobiologicals, Lisle, IL, USA). Aliquants of 300 µ plasma were assayed in duplicate. The sensitivity of the FSH RIA was 1-44 ng per assay tube with an intra-assay coefficient of variation (CV) of 9-3% and an inter-assay CV of 8-4%.
Plasma concentrations of LH were measured by RIA (Niswender el al., 1969 ) using antiserum to ovine LH provided by Dr G. D. Niswender. Highly purified ovine LH (LER-1056-C2) supplied by Dr L. E. Reichert, Jr was radioiodinated using chloramine-T. The standard preparation was bovine LH (NIH-LH-B9). The second anti¬ body was the same as that used in the FSH RIA. Aliquants of 200 µ plasma were assayed in duplicate. The sensitivity of this assay was 0-13 ng per assay tube, the intra-assay CV was 6-7%, and the inter-assay CV was 8-6%.
Progesterone was quantified in plasma samples by specific RIA (Beai et al., 1980) . Duplicate 100 pi samples were extracted with petroleum ether. The recovery of tritiated progesterone added to bovine plasma was 75-5 + 1-9% and the solvent blank was negligible. Assay values were not corrected for recovery. The sensitivity of this assay was 12-5 pg per assay tube, the intra-assay CV was 8-3% and the inter-assay CV was 9-7%.
Oestradiol-17ß (oestradiol) was measured in plasma samples using a modification of a commercially-available RIA (Second Antibody Estradiol; Diagnostic Products Corp., Los Angeles, CA, USA) recently validated for use in our laboratory. This assay method utilizes a specific oestradiol antiserum that exhibits very low cross-reactivities with related steroids (oestriol, 0-24%; androstenedione, 0004%; progesterone and testosterone, not detectable). Iodinated oestradiol serves as labelled ligand, and goat anti-rabbit gamma globulin with polyethyleneglycol ('precipitating solution') is used to separate bound and free ligand. Oestradiol standards (0-156-40 pg) diluted in assay buffer (0-1 % gelatin in phosphate-buffered saline) were prepared in our laboratory and substituted for the commercially available standard. Duplicate aliquants of 200 µ plasma were extracted with 2 ml diethyl ether. Recovery of iodinated oestra¬ diol added to bovine plasma was 86-2 ± 1-7% and the solvent blank was negligible. Values were not corrected for recovery. Extracts were dried under nitrogen, reconstituted in 200 pi assay buffer and stored overnight at 4°C to precipitate lipids. A 100-pl sample was removed from each reconstituted extract and assayed. To conduct the assay, anti-oestradiol antiserum (30 µ ) was added to standards and extracted samples and incubated at room temperature for 2h. Iodinated oestradiol (75 µ or 25 000 c.p.m.) was then added and the incubation continued for 1 h at room temperature. A 10-min incubation with 1 ml precipitating solution was followed by centrifugation at 2400 g for 20 min. Supernatants were decanted and precipitates counted. When aliquants of plasma from an ovariectomized heifer containing 0-17, 0-50, 1-50 or 4-50pg exogenous oestradiol/100µ were extracted and assayed, 0-25 + 001, 0-61 + 003, 212 + 006 and 5-5 + 0T6pg/100pl, respectively, were measured (n = 20). Oestradiol concentration in the plasma of the ovariectomized heifer (without added oestradiol) was near the limit of sensitivity of the assay (008 ± 001 pg/ µ ; « = 20). Concentrations of oestradiol in samples assayed using this method were compar¬ able to values previously derived from an established assay procedure in which extracts of the same samples were chromatographed before RIA No differences in circulating concentrations of LH were detectable between groups before, during or after bFF or saline treatment (Fig. lb) . All heifers exhibited evidence of a preovulatory LH surge. Plasma progesterone profiles and daily concentrations throughout the oestrous cycle did not differ between saline-and bFF-treated animals (data not shown), indicating normal development of corpora lutea by heifers in both treatment groups.
Small increases in plasma oestradiol were observed during the early luteal phase in both treat¬ ment groups (Fig. 2) . This increase occurred earlier in control heifers than in heifers treated with (Fig. 3) . Appearance of the first wave of follicular growth was significantly delayed by bFF treatment (Fig. 3) . In control heifers, newly recruited follicles ( > 5 mm in diameter) were first visible on Day 1 or Day 2 of the oestrous cycle (Day 1-4 ± 0-2). New follicles were not present in the ovaries of bFFtreated heifers before Day 2, and usually appeared on Day 3 or 4 (Day 3-3 ± 0-3; < 00001). Appearance of the first morphologically dominant follicle, defined as the day on which it could be retrospectively identified with a diameter of > 5 mm, was also delayed significantly by bFF treat¬ ment (P < 00001; Table 1 ). The day of the oestrous cycle on which this follicle reached maximal size, maximal size of the follicle, its persistence (total number of days the follicle could be identified with a diameter > 5 mm) and growth rate were not affected by bFF treatment. In control heifers, the dominant follicle of the first wave became visible either on the same day as the other follicles in its cohort or on the following day. The mean difference between appearance of newly recruited follicles and that of the first dominant follicle in the controls was 0-4 ± 0-2 days. This difference tended to be greater in bFF-treated animals, in which the dominant follicle usually appeared 1-2 days later than others in its cohort (mean difference = 1-2 + 0-3 days; = 0-087).
Characteristics of the second wave of follicular growth were also altered by bFF. New follicles appeared later in bFF-treated heifers (Day 12-7 + 0-4 compared with Day 10-4 + 0-6 in controls, < 001). Appearance of the second dominant follicle was also delayed in bFF-treated heifers (P < 001), and its maximal size was greater ( < 005; Table 2 ). The dominant follicle of the second wave tended to reach maximal size later in the oestrous cycle (P = 0064), and was on average less persistent in bFF-treated animals (P < 005). No differences in growth rates of the second dominant follicles were found between treatment groups. Appearance of dominant follicles in the second wave was not delayed relative to that of others in their respective cohorts.
Heifers treated with bFF tended to have greater total numbers of follicles with diameters >5mm (including dominant follicles) per wave of follicular growth. In the first wave, 6-6 + 1-2 follicles were detected in control animals while bFF-treated heifers had 10-2 + 1-4 follicles (P = 0086). In the second wave of growth, 50 + 0-6 follicles were observed in controls, compared with 6-8 + 0-8 in heifers receiving follicular fluid (P = 0084). Because only 1 of 6 heifers receiving bFF treatment exhibited 3 waves of follicular growth (Heifer 463), valid statistical comparisons regarding numbers of follicles and characteristics of dominant follicles in the third wave were not possible.
Discussion
Injections of bFF consistently suppressed the secondary FSH surge normally observed in heifers. Associated with this suppression were delays in follicular development, suggesting that the periovulatory increase in FSH secretion may play an important role in regulating patterns of ovarian follicular growth in cattle. To our knowledge, this is the first report linking the secondary FSH surge with follicular dynamics during the bovine oestrous cycle.
The endocrine responses to bFF observed in this study (Fig. 1) confirm previous results demon¬ strating in vivo the selective suppressive effect of charcoal-extracted bFF on FSH secretion in the absence of an effect on LH in female cattle . The dose of follicular fluid used suppressed plasma FSH during the normal time of the secondary surge to basal concentrations (i.e. concentrations in controls after the secondary surge). This magnitude of suppression was an important factor, since we did not wish to deprive follicles of basal gonadotrophin support by driving FSH below normal concentrations.
The significant elevation in plasma FSH concentrations over those of controls after the final bFF injections is similar to rebounds in FSH secretion described previously following treatment of intact heifers and ewes (Miller et al., 1982; McNeilly, 1984 McNeilly, , 1985 Wallace & McNeilly, 1985) with bFF. Although the reasons for the rebound effect are not completely understood, it seems that this transient increase in plasma FSH is related to the presence of the ovaries, since a rebound was not reported following bFF-induced sup¬ pression of FSH in ovariectomized heifers or in ovariectomized ewes treated with bFF or pure bovine inhibin (Findlay et al., 1987) . The rebound may reflect altered feedback relationships due to delayed follicular development (and hence lower endogenous production of inhibin and oestradiol). Because the rebound in plasma FSH observed in bFF-treated heifers in this study resembled the secondary FSH surge in controls, bFF-treatment in effect delayed the secondary surge of FSH by approximately 2 days.
In heifers treated with bFF the appearance of new follicles > 5 mm in diameter was delayed by about 2 days, suggesting that follicular recruitment for the first wave was delayed by suppression of the secondary FSH surge. This wave tended to consist of more follicles than the first wave of growth in control heifers, and these 'extra' follicles were probably recruited in response to the rebound of FSH, because plasma concentrations were usually elevated above those of controls around the time of appearance of new follicles in bFF-treated heifers. Concomitant with the delayed growth of new follicles was a delay in the appearance of the first dominant follicle following bFF treatment, suggesting that the secondary FSH surge may be important in initiating normal development of this follicle. In addition, it is possible that selection of the first dominant follicle was also affected by decreased FSH, since it tended to appear later than others in the first recruited cohort relative to the appearance of the dominant follicle in control heifers. These ideas are specu¬ lative, however, because there may be critical steps in follicular recruitment and selection that occur in the smaller, gonadotrophin-sensitive populations (Richards, 1980; Ireland, 1987) which cannot be accurately monitored by current ultrasonographic techniques.
Oestradiol was measured in samples taken during the first 10 days ofthe cycle to determine whether the delay in the first wave of follicular development in bFF-treated heifers was accompanied by changes in plasma oestradiol. The small increase observed in peripheral blood concentration during the early luteal phase confirms previous reports (Shemeshei al., 1972; Glencrosseí al., 1973) . Ireland & Roche (1983) have shown that single oestrogenic follicles are present in the ovary during early dioestrus. These follicles are presumably responsible for the rise of oestradiol detectable in the peripheral circulation at this time. The delayed growth of the first dominant follicle following bFF treatment compared with that of controls was clearly reflected in a corresponding delayed increase in oestradiol, with peak plasma concentrations occurring approximately 2 days after appearance of the first dominant follicle in both groups.
Although the development of the first dominant follicle was delayed by treatment with bFF, its eventual morphological dominance was accompanied by a period of several days when no new follicles were recruited (Fig. 3) . This observation illustrates the concept of functional dominance, the ability to inhibit further growth of antral follicles (Ireland & Roche, 1987) . Because this period of functional dominance during the first wave of follicular growth was similar in both treatment groups, the delayed appearance of follicles in the second wave in bFF-treated heifers was probably not a direct result of suppression of the secondary FSH surge, but rather an indirect consequence of the delay in the onset of the first wave. The larger average size and shorter persistence of the second dominant follicles in these animals can be explained by the fact that most (5/6) were ovulatory follicles, which have been shown to reach greater maximal diameters than the non-ovulatory domi¬ nant follicles usually observed during the second wave (Savio et al., 1988; . In contrast, only 1 of 5 second dominant follicles in control heifers was the ovulatory follicle.
Four of 5 control heifers (80%) exhibited 3 waves of follicular development during the cycle after prostaglandin synchronization, while the remaining heifer had 2 waves. Although 5 animals is a relatively small sample, these results confirm those of Savio et al. (1988) and , who reported that the majority of heifers examined ultrasonographically during natural oestrous cycles also exhibited 3 waves of growth. This common pattern was altered in heifers treated with bFF, with 5 of 6 animals exhibiting only 2 waves of follicular development. The lack of effect of bFF on plasma progesterone and length of oestrous cycles indicates that formation and function of corpora lutea were not impaired by bFF and that luteolysis occurred normally. There¬ fore, although the usual pattern of follicular development was delayed by bFF treatment, the time of luteal regression was not altered and consequently occurred while the dominant follicle of the second wave was present, leading to ovulation of that follicle. The only animal (Heifer 463) in the bFF-treated group that exhibited 3 waves also had the longest oestrous cycle (24 days), suggesting that the slightly longer luteal lifespan provided time for recruitment of a third wave and subsequent ovulation of the third dominant follicle.
Follicular fluid is a complex mixture containing a myriad of non-steroidal substances with potential functions in the regulation of folliculogenesis. These substances include inhibin, activins, FSH binding inhibitor, follicle regulatory protein, and growth factors (see Ireland, 1987; Tsafriri, 1988 , for reviews). Such components have been implicated in the inhibition of gonadotrophinstimulated follicle growth in follicular fluid-treated rats (Kling et al., 1984) and ewes (Cahill et al., 1985) . In contrast, other studies failed to demonstrate negative effects on follicular growth when bFF and exogenous FSH were administered together (McNeilly, 1985; Moser et ai, 1989) . We cannot ignore the possibility that inhibin or other factors in our preparation of bFF may have affected follicular development directly, independent of changes in pituitary FSH secretion. However, the consistent and significant delays in development of follicles associated with specific suppression of plasma FSH in this study suggest that the secondary FSH surge is important in reinitiating waves of follicular development following ovulation, and thus plays a role in the regulation of patterns of ovarian follicular development in cattle.
